Off-label use of recombinant activated factor VII in hemophagocytic lymphohistiocytosis patients with major bleeding.

已完结 10 由 necromme 发布于 2026/6/15 16:31:00

DOI:10.1080/10428194.2025.2472923
作者：Yahong You,?Dina Suolitiken,?Lin Wu,?Yubo Pi,?Leilei Chen,?Deli Song,?Zhengyang Song,?Zhao Wang,?Jingshi Wang
文献类型：期刊论文
补充材料：只需要正文

Taylor & Francis

Abstract：Hemophagocytic lymphohistiocytosis (HLH) is a fatal multi-systemic disorder. Patients with HLH are more prone to bleeding, which implies a poor outcome. The objective was to investigate the

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:Institute of Electrical and Electronics Engineers (IEEE)Quality Evaluation of Resistance Spot Welding Based on Dynamic Reactance Signal and Radar Diagram Method